FDA Investigator Denise L Terzian
Denise L Terzian has conducted inspections on 167 sites in 1 countries as of 08 Apr 2008. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
167
Last Inspection Date:
08 Apr 2008
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Denise L Terzian:
Alan R Condon,
Alia Legaux,
Alice C Silva,
Amy Kim,
Amy Wyan Mai,
Andrew F Cohen,
Ann B Okon,
Anne Marie Dubrey,
Anthony N Onianwa,
Arduino Frankovic,
Arthur F Walker,
Bruce G Cooper,
Cara M Minelli,
Carolyn J Cook,
Cassandra L Abellard,
Catherine M Beer,
Charisse K Green,
Charla L Glenister,
Cynthia H Lafountain,
Dana A Razzano,
Dave M Deroche,
Diane M Fresch,
Dipesh K Shah,
Donald G Gordon,
Donald J Ullstrom,
Donald L Kass,
Donna D Gallien, MPH,
Edmund F Mrak, Jr,
Ellen M Landis,
Evelyn Taha,
Felix Maldonado,
George C Amedro,
Gerald T O'connor,
Gerard D Difiore,
Irina Gaberman,
Jacobson,
Jacqueline S Warner,
James A Liubicich,
Jason Kwong,
Jerri E Lothrop,
Joan A Loreng,
Joel R Powers,
Jonah S Ufferfilge,
Jonathan G Matrisciano,
Joseph J Vannelli,
Joseph Maselli,
Joseph Milcetic,
Joy P Matthias,
Juan Rjimenez Garcia,
Judy Keihl,
Julie Scoma,
Karen A Briggs,
Karen L Kosar,
Katherine E Jacobitz,
Kathryn A Nagy,
Kenneth G Klobus,
Kevin A Gonzalez,
Kimberley A Ricketts,
Kimberly Y Smithson,
Kwong P Lee,
Lawrence H Patrick,
LCDR Chad N Thompson,
Lea M Landi,
Leena Thomas,
Linda M Sacco,
Lisa M Romano,
LTJG Matthew R Palo,
Margaret E Sarles,
Marlene L Davis,
Mary M Finn,
Meghan L Fetterly,
Meisha A Mandal,
Melissa A Henaghan,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael G Sinkevich,
Michael R Dominick,
Michael W Burd,
Michelle L Dragon Nagel,
Mindy M Chou,
Nancy A Saxenian Emmons,
Nicholas C Mendiola,
Onieka T Carpenter,
Paul E Stein,
Perez,
Perry T Nichols,
Peter M Trunk,
Peter R Caparelli,
Rajiv R Srivastava,
Randi Lynn Spencer,
Richard K Glabach,
Robert J Veitch,
Russ E Davis,
Sarah Forney,
Sasha M Latonis,
Scott M Loughan,
Scott R Izyk,
Shreya Shah,
Sony Mathews,
Steven C Nattrass,
Steven J Libal,
Sung K Kim,
Uduak M Inokon,
Valerie A Potopsingh,
Walter H Stanley,
Wayne S Thompson,
Wendy M Stone,
William C Lubas,
William M Rennells,
William P Chilton,
Willy A Orantes,
Yvonne M Santiago
Denise L Terzian's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2006 | FDA 483 | Ohm Laboratories, Inc. - Form 483, 2006-08-30 |
December, 2006 | FDA 483 | SiCap Industries, LLC - Form 483, 2006-12-08 |
March, 2001 | EIR | Peter J. Piliero, M.D. - EIR, 2001-03-13 |
June, 2002 | EIR | Albany Medical Center Hospital Blood Bank - EIR, 2002-06-12 |
March, 2001 | FDA 483 | Peter J. Piliero, M.D. - Form 483, 2001-03-13 |
June, 2005 | FDA 483 | Joel M. Kremer - Form 483, 2005-06-23 |
July, 2006 | FDA 483 | Ames Goldsmith Corp - Form 483, 2006-07-19 |
May, 2002 | FDA 483 | University of Vermont Health Network CVPH - Form 483, 2002-05-23 |
June, 2005 | EIR | Joel M. Kremer - EIR, 2005-06-23 |
January, 2000 | FDA 483 | Basf Corporation - Form 483, 2000-01-10 |
October, 2002 | EIR | Peter J. Piliero, M.D. - EIR, 2002-10-17 |
February, 2007 | EIR | Ohm Laboratories, Inc. - EIR, 2007-02-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more